RotaChrom Technologies Unveils Laboratory-Scale Chromatographic Method Development Platform
April 26, 2024
Revolutionary CPC Modeler Platform Promises Quick Method Development and Testing Kecskemet, Hungary – RotaChrom® Technologies PLC proudly announces the launch of the CPC Modeler, a desktop-sized centrifugal partition chromatography (CPC) method-development platform. Known for its industrial-scale devices, RotaChrom has now expanded its portfolio to include a lab-scale device, designed specifically for researchers and laboratories. The [...]
Bio-Rad Announces Life Science Group Management Changes
April 26, 2024
HERCULES, Calif. -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the Life Science Group, effective May 1, 2024. He [...]
April 26, 2024
New MBT Pathfinder® IVD robot for automated MALDI Biotyper® target preparation New LiquidArray® MTB-XDR panel for simultaneous detection of M. tuberculosis complex bacteria, and their resistances to five WHO-recommended second-line drugs against multidrug-resistant tuberculosis Pending ELITech acquisition has received all regulatory clearances; closing now expected in the second quarter of 2024 BARCELONA, Spain -- At the ESCMID Global 2024 conference, Bruker is [...]
April 26, 2024
Combination of leading nanopore sequencing technology with cloud-based SAAS analysis platform will help microbiologists gain critical infectious disease insights from genomic data OXFORD, UK — Oxford Nanopore Technologies (Oxford Nanopore) the company behind a new generation of molecular sensing technology based on nanopores, and BugSeq, a leading provider of fully automated infectious disease bioinformatics services, [...]
April 25, 2024
PanOmiQ completes Whole Genome Sequencing analysis with a clinical report in 7 hours. CALGARY, AB - BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human genome. With unparalleled speed, precision, and [...]
GMP Compliant Cell Culture Medium Streamlines API Manufacture
April 25, 2024
AMSBIO has launched an enhanced GMP-compliant version of its animal-origin-free, chemically defined StemFit™ iPSC expansion medium. StemFit™ Basic04 CT is designed to improve the growth and pluripotency of induced pluripotent stem cells (iPSC) and meet the Good Manufacturing Practice (GMP) standards for Active Pharmaceutical Ingredients (API). Offering superior iPSC performance, expansion, and maintenance of long-term genetic stability - [...]
April 25, 2024
EchoLUTION Tissue RNA Kit is suitable for the extraction of a variety of tissues. Simple and fast extraction with a highly pure RNA outcome. Sustainable option eliminating the need to use phenol/chloroform . BioEcho Life Sciences, the biotechnology company supplying fast and sustainable nucleic acid extraction technologies, has launched its latest product: the EchoLUTION Tissue RNA [...]
April 25, 2024
New protocol for use in infectious disease research part of packed activity lineup for ESCMID Global 2024 OXFORD, UK — Oxford Nanopore Technologies (Oxford Nanopore), the company behind a new generation of molecular sensing technology based on nanopores, today announced its lineup of speakers and conference activities for the upcoming annual meeting of the European [...]
April 25, 2024
Oxford, UK – Oxford Nanopore Technologies (Oxford Nanopore) today announced the launch of its Compatible Products Programme, a new initiative designed to establish and showcase approved compatible third-party products, ensuring seamless use in combination with Oxford Nanopore’s sequencing products. The programme will expand the network of products compatible with Oxford Nanopore’s platform to enhance the overall [...]
Merck Invests More Than € 300 Million in New Life Science Research Center in Germany
April 25, 2024
German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony Research center to accelerate biopharmaceutical product development Part of Merck’s € 1.5 billion investment program in Darmstadt by 2025 DARMSTADT, GERMANY -- Merck, a leading science and technology company, is investing more than € 300 million in a new research [...]